ArticleRheumatology advances in practice2024

Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysis.

Sean P Gavan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.